This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Randall S. Burd, MD; Carolyn S. Cody, MD; Christopher S. Raymond; David L. Dunn, MD, PhD

Arch Surg. 1993;128(2):145-151.

Abstract
• In this study, we sought to determine the mechanism(s) by which a type-specific anti—lipopolysaccharide monoclonal antibody (an IgG directed against the O-antigen polysaccharide region of Salmonella minnesota lipopolysaccharide) and its F(ab')₂ fragments protect during gram-negative bacterial peritonitis and endotoxemia in mice. During peritoneal infection, (1) IgG significantly decreased mortality, bacteremia, and endotoxemia at all time points compared with saline solution pretreatment and (2) F(ab')₂ fragments reduced mortality at 24 hours but not thereafter, and had no effect on bacteremia but reduced endotoxemia compared with saline solution pretreatment. In the endotoxin model, IgG pretreatment significantly reduced mortality compared with saline solution pretreatment, while F(ab')₂ fragments had no significant effect on mortality. No difference in endotoxemia was observed in mice that received IgG, F(ab')₂ fragments, or saline solution pretreatment during endotoxemia. These results suggest that type-specific anti—lipopolysaccharide monoclonal antibodies protect by Fc-mediated clearance of both bacteria and endotoxin.

(Arch Surg. 1993;128:145-151)

Author Affiliations
From the Department of Surgery, Division of Surgical Infectious Diseases, University of Minnesota, Minneapolis.

Footnotes
Accepted for publication September 26, 1992.

Presented at the 12th Annual Meeting of the Surgical Infection Society, Los Angeles, Calif, April 9, 1992.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?